Pharmaceutical Composition for Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyacrylate Derivatives
申请人:Kim Bum Tae
公开号:US20080280901A1
公开(公告)日:2008-11-13
The present invention relates to a use of a specific alpha-arylmethoxyacrylate derivative, or its pharmacologically acceptable salt or solvate for preventing and treating metabolic bone diseases.
Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
申请人:KIM Bum Tae
公开号:US20100256367A1
公开(公告)日:2010-10-07
The present invention relates to a use of a specific alpha-arylmethoxyacrylate derivative, or its pharmacologically acceptable salt or solvate for preventing and treating metabolic bone diseases.
Asymmetric aldol reaction: A highly -selective aldol reaction between tricarbonyl(-trimethylsilylbenzaldehyde derivative )-chromium (0) complexes and cyclic silyl enol ethers
作者:Chisato Mukai、Won Jea Cho、In Jong Kim、Masaru Kido、Miyoji Hanaoka
DOI:10.1016/s0040-4020(01)96032-6
日期:1991.5
Reaction of (±)-chromium (0) -complexes 4e-g with 5–7 gave the isomers in a highly selective manner. This aldol reaction was successfully applied to the asymmetric one. The absolute configuration was determined by X-ray analysis of (—)--8e.